As expected, the enrichment of CRH receptor activity, represented by CRHR1 and CRHR2, as well as the enrichment of dopamine neurotransmitter receptor activity, particularly through Gi/Go signaling, indicates their involvement in the molecular processes underlying PTSD. The gene discussed is CRHR1; the disease is post-traumatic stress disorder.